+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rubella Drug"

Rubella - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Rubella - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Rubella (German Measles) - Pipeline Review, H2 2020 - Product Thumbnail Image

Rubella (German Measles) - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 45 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Rubella is a viral infection caused by the rubella virus. It is typically mild and can be treated with rest and fluids. Infectious Diseases Drugs are used to treat and prevent the spread of infectious diseases, including rubella. These drugs can be used to reduce the severity of symptoms, prevent complications, and reduce the risk of transmission. The Rubella Drug market is composed of a variety of drugs used to treat and prevent the spread of rubella. These drugs include antiviral medications, immunoglobulins, and vaccines. Antiviral medications are used to reduce the severity of symptoms and prevent complications. Immunoglobulins are used to boost the body's immune response to the virus. Vaccines are used to prevent the spread of the virus. Some companies in the Rubella Drug market include GlaxoSmithKline, Merck, Pfizer, Sanofi, and Johnson & Johnson. Show Less Read more